Benjamin Hsu

6.7k citations

91 papers · 5.2k indexed · 2 hit papers · h-index 36

Impact in

Rheumatology top 0.2%
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
Immunology top 0.5%
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Psoriasis: Treatment and Pathogenesis
- Immunotherapy and Immune Responses

Papers in

Rheumatology 55
- Rheumatoid Arthritis Research and Therapies 44
- Spondyloarthritis Studies and Treatments 26
- Systemic Lupus Erythematosus Research 13
Biological Psychiatry 6

Co-authors: William F. Hickey Hironobu Kimura Jürgen Braun Désirée van der Heijde Paul M. Allen Robert D. Inman Michael P. Cancro M. Mack
Journals: Annals of the Rheumatic Diseases (33 papers)The Journal of Immunology (5 papers)The Journal of Rheumatology (4 papers)Arthritis Care & Research (4 papers)Modern Rheumatology (2 papers)
Partner nations: United States Canada Germany

In The Last Decade

Benjamin Hsu

87 papers receiving 5.0k citations

Hit Papers

align trajectories log scale

Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double‐blind, placebo‐controlled, phase III trial 2008 · 444 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2008 Arthritis & Rheumatism
1991 Journal of Neuroscience Research

Peers

Countries citing papers authored by Benjamin Hsu

Since Specialization

Citations

This map shows the geographic impact of Benjamin Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Hsu more than expected).

Fields of papers citing papers by Benjamin Hsu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Hsu. The network helps show where Benjamin Hsu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Benjamin Hsu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Benjamin Hsu Line = papers co-authored together Benjamin Hsu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	M3T: A New Benchmark Dataset for Multi-Modal Document-Level Machine Translation Benjamin Hsu, P. R. Meher*, U. A. Jiwantare, V. T. Dhurvey, Huayang Li, P. Boudra, Maria Nădejde, Xing Niu, Ron Litman, Fintan McAdam, Raghavendra Pappagari	2024	2
2	Feasibility of manufacture of chimeric antigen receptor-regulatory T cells from patients with end-stage renal disease SHILAP Revista de lepidopterología ·Alireza Jahany, Manjiang Yang, Д.Ю. Чудинова, Benjamin Hsu, Albert Macho Algàs, Claire Chapman, Emily J Culme-Seymour, Gillian Atkinson, Diego Cantarovich	2023	2
3	RAMP: Retrieval and Attribute-Marking Enhanced Prompting for Attribute-Controlled Translation University of Groningen research database (University of Groningen / Centre for Information Technology) ·Stephanie Tapia Walker, Phu Mon Htut, Xing Niu, Benjamin Hsu, Anna Currey, Georgiana Dinu, Maria Nădejde	2023	2
4	Study Design: Human Leukocyte Antigen Class I Molecule A∗02-Chimeric Antigen Receptor Regulatory T Cells in Renal Transplantation Kidney International Reports ·Katharina Schreeb, Emily J Culme-Seymour, Mary E. Gawley, Rifqi Fajar Maulana, Gillian Atkinson, Benjamin Hsu, Petra Reinke	2022	35
5	Effects of immunomodulatory drugs on depressive symptoms: A mega-analysis of randomized, placebo-controlled clinical trials in inflammatory disorders Molecular Psychiatry ·Gayle Wittenberg, Annie Stylianou, Yun Zhang, Yu Sun, Ashutosh Gupta, Akinaly Turgunalievich Tokonov, Dai Wang, Benjamin Hsu, Mark Curran, Shahid A. Khan, Guang Chen, Edward T. Bullmore, Wayne C. Drevets	2019	128
6	Efficacy and safety of sirukumab in Japanese patients with active rheumatoid arthritis who were refractory or intolerant to anti-tumor necrosis factor therapy: Subgroup analysis of a randomized, double-blind, multicenter, phase 3 study (SIRROUND-T) Modern Rheumatology ·Yoshiya Tanaka, Tsutomu Takeuchi, Masayoshi Harigai, Hisashi Yamanaka, Tiffany Sue, Saeed Lehrasab, Sergey S. Gorbunov, Benjamin Hsu	2018	3
7	Sirukumab: A Potential Treatment for Mood Disorders? Advances in Therapy ·Aileen J. Zhou, Yena Lee, Giacomo Salvadore, Benjamin Hsu, Trehani M. Fonseka, Sidney H. Kennedy, Roger S. McIntyre	2016	24
8	Results of A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of The Efficacy And Safety of Sirukumab, An Anti-IL-6 Cytokine Monoclonal Antibody, In Patients with Active Rheumatoid Arthritis Despite Disease-Modifying Anti-Rheumatic Drug Treatment (Sirround-D) Value in Health ·Tsutomu Takeuchi, Carter Thorne, George Karpouzas, Wendy Faisury Izquierdo Calderón, W. Xu, R. Bhima Rao, Charles C. Lanfear, Benjamin Hsu	2016	2
9	Five-year Safety Data from 5 Clinical Trials of Subcutaneous Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis The Journal of Rheumatology ·Jonathan Kay, Roy Fleischmann, Edward Keystone, Elizabeth C. Hsia, Benjamin Hsu, Yiying Zhou, Neil Goldstein, Jürgen Braun	2016	29
10	Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 5-year results of the GO-RAISE study Annals of the Rheumatic Diseases ·Atul Deodhar, Jürgen Braun, Robert D. Inman, Désirée van der Heijde, Yiying Zhou, Stephen Xu, Chenglong Han, Benjamin Hsu	2014	101
11	The effect of golimumab on haemoglobin levels in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis Lara D. Veeken ·Daniel E. Fürst, Jonathan Kay, Mary Chester Wasko, Edward Keystone, Arthur Kavanaugh, Atul Deodhar, Frederick T. Murphy, Jeanette H. Magnus, Elizabeth C. Hsia, Benjamin Hsu, Stephen Xu, Mahboob U. Rahman, Mittie K. Doyle	2013	26
12	In Ankylosing Spondylitis, a Decrease in MRI Spinal Inflammation Predicts Improvement in Spinal Mobility Independently of Patient Reported Symptomatic Improvement Data Archiving and Networked Services (DANS) ·Patrícia Maria Abreu Machado, Robert Landewé, Jürgen Braun, Xenofon Baraliakos, Kay‐Geert Hermann, Benjamin Hsu, David W. Baker, Fāi sapphayākǭn thammachāt læ sing wǣt lǭm	2012	0
13	Comparison of three methods for calculating the Bath Ankylosing Spondylitis Metrology Index in a randomized placebo‐controlled study Arthritis Care & Research ·Désirée van der Heijde, Atul Deodhar, Robert D. Inman, Jürgen Braun, Benjamin Hsu, M. Mack	2012	21
14	Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 104-week results of the GO-RAISE study Annals of the Rheumatic Diseases ·Jürgen Braun, Atul Deodhar, Robert D. Inman, Désirée van der Heijde, M. Mack, Stephen Xu, Benjamin Hsu	2011	82
15	Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo- controlled GO-RAISE study Annals of the Rheumatic Diseases ·Jürgen Braun, Xenofon Baraliakos, Kay‐Geert Hermann, Désirée van der Heijde, Robert D. Inman, Atul Deodhar, Anna Baratelle, Stephen Xu, Weichun Xu, Benjamin Hsu	2011	72
16	Biodegradable fibrous scaffolds with diverse properties by electrospinning candidates from a combinatorial macromer library Acta Biomaterialia ·Robert B. Metter, Jamie L. Ifkovits, 均熊田, L. Vincent, Benjamin Hsu, Selia Ng'anjo, Robert L. Mauck, Jason A. Burdick	2009	20
17	Cutting Edge: BLyS Enables Survival of Transitional and Mature B Cells Through Distinct Mediators The Journal of Immunology ·Benjamin Hsu, R. Pooyyania, R. Coleman Lindsley, David M. Hilbert, Michael P. Cancro	2002	255
18	Competition for BLyS-mediated signaling through Bcmd/BR3 regulates peripheral B lymphocyte numbers Current Biology ·R. Pooyyania, Vicky M. Lentz, Gao Sishan, Benjamin Hsu, Karen Clise-Dwyer, David M. Hilbert, Colleen E. Hayes, Michael P. Cancro	2001	135
19	Endogenous altered peptide ligands can affect peripheral T cell responses. The Journal of Experimental Medicine ·Karine Vidal, Benjamin Hsu, Calvin B. Williams, Paul M. Allen	1996	51
20	Modulation of T cell development by an endogenous altered peptide ligand. The Journal of Experimental Medicine ·Benjamin Hsu, Brian D. Evavold, Paul M. Allen	1995	41

About Benjamin Hsu

Benjamin Hsu is a scholar working on Rheumatology, Biological Psychiatry, Hematology, Immunology and Genetics, having authored 91 papers that have together received 5.2k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (44 papers), Spondyloarthritis Studies and Treatments (26 papers), Autoimmune and Inflammatory Disorders Research (19 papers), Chronic Lymphocytic Leukemia Research (13 papers), Systemic Lupus Erythematosus Research (13 papers), Monoclonal and Polyclonal Antibodies Research (13 papers), T-cell and B-cell Immunology (13 papers) and Psoriasis: Treatment and Pathogenesis (11 papers). The work is most often cited by research in Rheumatology (2.3k citations), Immunology (2.9k citations), Biological Psychiatry (234 citations), Hematology (769 citations) and Neurology (446 citations). Benjamin Hsu has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include William F. Hickey, Hironobu Kimura, Jürgen Braun, Désirée van der Heijde, Paul M. Allen, Robert D. Inman, Michael P. Cancro, M. Mack, Brian D. Evavold and Stephen Xu. Their work appears in journals such as Annals of the Rheumatic Diseases, The Journal of Immunology, The Journal of Rheumatology, Arthritis Care & Research and Modern Rheumatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact